UNSPSC 51284108: Ceftazidime

This classification denotes a cephalosporin antibiotic, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 9M416Z9QNR. European Medicines Agency schedules Ceftazidime pentahydrate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01134MIG. Ceftazidime generally arises in the molecular formula C22H22N6O7S2. The term CEFTAZIDIME is a European Pharmacopoeia designation. CEFTAZIDIME is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.

UNSPSC 51284108 Ceftazidime is a Commodity code nominally designating a specific antibiotic pharmaceutical, but recent state and local solicitations tagged with this code show no actual procurement of ceftazidime itself. Instead, the opportunities in the record involve broader pharmaceutical, medical supply, and pharmacy benefit program work — naloxone and drug deactivation systems, fire department first-aid supplies, generic multi-source pharmaceuticals and OTC products, and direct-to-manufacturer prescription program design. The issuing bodies span state health agencies (Texas Health and Human Services Commission), county health departments (Seminole County, Florida), municipal fire and rescue services (City of Tampa), and multi-state cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, MMCAP). The code shows little relevant recent activity for ceftazidime specifically; the mismatch between the code's nominal scope and the actual work being solicited suggests these opportunities have been tagged to a broad pharmaceutical commodity classification rather than to the specific drug product.

Geographic activity centers on Florida (Seminole County), Texas (state-level HHS), Minnesota (MMCAP, which includes Oregon), and the broader multi-jurisdictional scope of cooperative purchasing contracts. Representative recent opportunities include Seminole County's IFB 60459723LAS (posted June 30, 2026, due July 26, 2023) for 1,900 units of naloxone and 800 drug deactivation systems annually with quarterly deliveries; City of Tampa's IFB 26P00145 (posted March 25, 2026, due March 13, 2026) for 169 line items of medical and first-aid supplies for the Fire Department Rescue Division, designated as a sheltered market procurement for certified Small Local Business Enterprises with an estimated contract value of $700,000; Texas HHS Commission's RFI HHS0017013 (posted April 3, 2026, deadline April 3, 2026) soliciting vendor capabilities for a Therapeutic Pharmacy Initiative direct-to-manufacturer prescriptions program; and MMCAP's RFP S1070000015802 (due March 26, 2026) for generic multi-source pharmaceuticals and OTC products across multi-state participants. No procurement activity specifically for ceftazidime appears in the recent record.